YCBD - cbdMD, Inc.
IEX Last Trade
0.5
0 0%
Share volume: 0
Last Updated: Fri 20 Dec 2024 09:19:56 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.51%
PREVIOUS CLOSE
CHG
CHG%
$0.50
-0.16
0.46%
View ratios
| Fiscal Date | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
| Report Date | 2022-02-10 | 2022-05-13 | 2022-08-11 | 2022-12-15 | 2023-02-13 | |
| Total revenue | 9.322 M | 9.629 M | 8.593 M | 7.860 M | 6.085 M | |
| Cost of revenue | 4.328 M | 3.187 M | 2.660 M | 2.892 M | 2.517 M | |
| Gross profit | 4.994 M | 6.442 M | 5.933 M | 4.968 M | 3.568 M | |
| 29.01% | -7.91% | -16.26% | -28.19% | |||
| Operating expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Selling general and admin | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 16.284 M | 14.639 M | 10.943 M | 10.848 M | 10.131 M | |
| -10.10% | -25.25% | -0.87% | -6.60% | |||
| Operating income | -6.962 M | -5.010 M | -2.350 M | -2.988 M | -4.046 M | |
| Ebit | -6.962 M | -5.010 M | -2.350 M | -2.988 M | -4.046 M | |
| Pretax income | -19.161 M | -4.657 M | -31.634 M | -14.631 M | -3.956 M | |
| -75.69% | 579.25% | -53.75% | -72.96% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -20.161 M | -5.658 M | -32.635 M | -15.632 M | -4.957 M | |
| 71.94% | -476.82% | 52.10% | 68.29% | |||
| Net income | -20.161 M | -5.658 M | -32.635 M | -15.632 M | -4.957 M | |
| 71.94% | -476.82% | 52.10% | 68.29% |